Product
Licart
Aliases
diclofenac epolamine, Licart™ (diclofenac epolamine) topical system
Name
Flector
INN Name
Diclofenac Epolamine
FDA Approved
Yes
1 clinical trial
10 organizations
1 indication
3 documents
Indication
Soft Tissue InjuriesClinical trial
A Multi-center, Prospective, Open-label, Controlled Study of the Pharmacokinetics and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue InjuriesStatus: Recruiting, Estimated PCD: 2024-06-15
Organization
Unit Dose ServicesDocument
DailyMed Label: FlectorOrganization
Rebel Distributors Corp.Organization
Quality Care Products, LLCOrganization
IBSA Pharma Inc.Document
DailyMed Label: LICARTOrganization
Greenstone LLCOrganization
Advanced Rx Pharmacy of Tennessee, LLCOrganization
YARAL Pharma Inc.Organization
Teva Pharmaceuticals USA Inc.Organization
Asclemed USA, Inc.Organization
Physicians Total Care, Inc.